[Measures to meet the side effects of the orally administered antihyperglycemic drugs].
Ishii
J
J
Fourth Department of Internal Medicine, Saitama Medical School.
Inoue
I
I
D020909:Acarbose; D000284:Administration, Oral; D000818:Animals; D001645:Biguanides / Q000008:administration & dosage / Q000009:adverse effects; D002319:Cardiovascular System / Q000187:drug effects; D002839:Chromans / Q000009:adverse effects; D004347:Drug Interactions; D065089:Glycoside Hydrolase Inhibitors; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007294:Inositol / Q000009:adverse effects / Q000031:analogs & derivatives; D007333:Insulin Resistance; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects; D013844:Thiazoles / Q000009:adverse effects; D045162:Thiazolidinediones; D014312:Trisaccharides / Q000009:adverse effects; D000077288:Troglitazone
D001645:Biguanides; D002839:Chromans; D065089:Glycoside Hydrolase Inhibitors; D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D013844:Thiazoles; D045162:Thiazolidinediones; D014312:Trisaccharides; D007294:Inositol; D000077288:Troglitazone; C102817:voglibose; D020909:Acarbose